Related references
Note: Only part of the references are listed.Flu myths: Dispelling the myths associated with live attenuated influenza vaccine
Pritish K. Tosh et al.
MAYO CLINIC PROCEEDINGS (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology
Sonya L. Cyr et al.
VACCINE (2007)
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
Torbjorn Ramqvist et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1
Joost H. C. M. Kreijtz et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Avian and pandemic influenza: An overview
Gregory A. Poland et al.
VACCINE (2007)
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine - A randomized controlled trial
John J. Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Vaccine delivery methods using viral vectors
Andreas Brave et al.
MOLECULAR PHARMACEUTICS (2007)
Use of viral vectors for the development of vaccines
Matthias Liniger et al.
EXPERT REVIEW OF VACCINES (2007)
Scientific barriers to developing vaccines against avian influenza viruses
Kanta Subbarao et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
Suzanne E. Ohmit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The virosomal influenza vaccine Invivac®:: Immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad®) in elderly subjects
I. A. de Bruijn et al.
VACCINE (2006)
Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years:: A prospective cohort study
L. Salleras et al.
VACCINE (2006)
DNA vaccines: Recent developments and future possibilities
Margaret A. Liu et al.
HUMAN GENE THERAPY (2006)
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
Robert L. Atmar et al.
CLINICAL INFECTIOUS DISEASES (2006)
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections
Shai Ashkenazi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
Douglas M. Fleming et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
Deborah H. Fuller et al.
METHODS (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines
William A. Ernst et al.
VACCINE (2006)
Epidermal DNA vaccine for influenza is immunogenic in humans
Robert J. Drape et al.
VACCINE (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits
S Wimer-Mackin et al.
VACCINE (2006)
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses
AD Altstein et al.
ARCHIVES OF VIROLOGY (2006)
Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting
DA Buonagurio et al.
VIROLOGY (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults
JM Langley et al.
VACCINE (2006)
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity
H Bakke et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects
J Treanor et al.
VACCINE (2006)
Evolving strategies for the prevention of influenza infection - Potential for multistrain targeting
Brian D. Livingston et al.
BIODRUGS (2006)
The 'co-delivery' approach to liposomal vaccines: Application to the development of influenza-A and hepatitis-B vaccine candidates
Peter Laing et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
Removing barriers to global pandemic influenza vaccination
Gigi Kwik Gronvall et al.
BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE (2006)
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice
P Pushko et al.
VACCINE (2005)
Current concepts - Avian influenza A (H5N1) infection in humans
H Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses
DP Ritzwoller et al.
PEDIATRICS (2005)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch
SA Frech et al.
VACCINE (2005)
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
JA Fan et al.
VACCINE (2004)
Current status of live attenuated influenza virus vaccine in the US
RB Belshe
VIRUS RESEARCH (2004)
Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers
IA de Bruijn et al.
VIRUS RESEARCH (2004)
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination
ST Rottinghaus et al.
VACCINE (2003)
Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children - A randomized controlled trial
A Hoberman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2
K Mozdzanowska et al.
VACCINE (2003)
New technology platforms in the development of vaccines for the future
R Glück et al.
VACCINE (2002)
Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines
BR Murphy et al.
VIRAL IMMUNOLOGY (2002)
The evolving rote of oral insulin in the treatment of diabetes using a novel RapidMist (TM) System
P Modi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Influenza vaccine effectiveness among elderly nursing home residents: A Cohort Study
AS Monto et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines
MG Pau et al.
VACCINE (2001)
Induction of antigen-specific CD8+T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
MJ Roy et al.
VACCINE (2000)
Effectiveness and cost-benefit of influenza vaccination of healthy working adults - A randomized controlled trial
CB Bridges et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
RB Belshe et al.
JOURNAL OF PEDIATRICS (2000)
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
DR Feikin et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Share Paper
